Prescribing InformationDARZALEX FASPRO ® PRESCRIBING INFORMATION DARZALEX FASPRO ® LA información de prescripción DARZALEX® PRESCRIBING INFORMATION For US Patients Download Dosing & Administration Guide
Prescribing InformationDARZALEX FASPRO® Prescribing Information DARZALEX FASPRO® LA información de prescripción DARZALEX® Prescribing Information Important Safety InformationDARZALEX FASPRO® Important Safety Information DARZALEX® Important Safety Information Contact Us1-800-JANSSEN Email Medical Information Center Search JanssenMD Contact Us For US Patients DOWNLOAD DOSING & ADMINISTRATION GUIDE For US Healthcare Professionals Looking for DARZALEX® (daratumumab)? GET IN TOUCH Home Looking for DARZALEX® (daratumumab)? GET IN TOUCH Treatment RegimensApproved Indications NCCN Recommendations Clinical TrialsColumbaStudy Design Efficacy Safety PleiadesStudy Design Efficacy Safety Dosing & AdministrationMechanism of ActionScience Behind DARZALEX FASPRO® AdministrationSubcutaneous Administration Dosing ScheduleNewly DiagnosedDRd DVMP DVTd Relapsed or RefractoryDRd DVd Monotherapy Want to see how DARZALEX FASPRO® is administered step by step? Watch the Dosing & Administration video For NursesGetting Started Administration Resources Patient & Practice ResourcesHCP Resources Pharmacist Resources Patient Resources Janssen CarePath Learn about the support resources available for your patients Explore Janssen CarePath Looking for DARZALEX® (daratumumab)? GET IN TOUCH X GET IN TOUCH If you are a US healthcare professional, please provide your ZIP code and contact information below if you would like us to get in touch with you. The information you provide will be used by Janssen Biotech, Inc., our affiliates, and our service providers to contact you. Our Privacy Policy further governs the use of the information you provide. By providing the information and selecting the SUBMIT button, you indicate that you read, understand, and agree to these terms. *Required field. Topics * [Select]Contact a Janssen Clinical Educator for Subcutaneous Administration Training and EducationContact a Janssen Sales representative for Product Information First Name * Last Name * Email * Phone Number * ZIP Code * Specialty * [Select]PhysicianNurse PractitionerPhysician AssistantRegistered NursePharmacistOther yes no Rep_found Submit
GET IN TOUCH If you are a US healthcare professional, please provide your ZIP code and contact information below if you would like us to get in touch with you. The information you provide will be used by Janssen Biotech, Inc., our affiliates, and our service providers to contact you. Our Privacy Policy further governs the use of the information you provide. By providing the information and selecting the SUBMIT button, you indicate that you read, understand, and agree to these terms. *Required field.
Home Treatment Regimens Approved Indications NCCN Recommendations Clinical Trials Columba Study Design Efficacy Safety Pleiades Study Design Efficacy Safety Dosing & Administration Mechanism of Action Science Behind DARZALEX FASPRO® Administration Subcutaneous Administration Dosing Schedule Newly Diagnosed DRd DVMP Relapsed or Refractory DRd DVd Monotherapy For Nurses Getting Started Administration Resources Patient & Practice Resources HCP Resources Pharmacist Resources Patient Resources Janssen CarePath